CUMYL-PICA

From Wikipedia, the free encyclopedia
Jump to: navigation, search
CUMYL-PICA
CUMYL-PICA structure.png
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
Formula C23H28N2O
Molar mass 348.49 g/mol
3D model (Jmol)

CUMYL-PICA (SGT-56) is an indole-3-carboxamide based synthetic cannabinoid. It is the α,α-dimethylbenzyl analogue of SDB-006.[1] It was briefly sold in New Zealand during 2013 as an ingredient of at the time legal synthetic cannabis products, but the product containing CUMYL-BICA and CUMYL-PICA was denied an interim licensing approval under the Psychoactive Substances regulatory scheme, due to reports of adverse events in consumers.[2] CUMYL-PICA acts as a potent agonist for the cannabinoid receptors, with approximately 20x selectivity for CB1, having an EC50 of 0.66nM for human CB1 receptors and 13nM for human CB2 receptors.[3]

See also[edit]

References[edit]

  1. ^ "CUMYL-PICA". Cayman Chemical. Retrieved 8 July 2015. 
  2. ^ The Risk Assessment Score Table. New Zealand Ministry of Health, 27 September 2013
  3. ^ Bowden; et al. (11 April 2013). "Patent WO 2014167530 - Cannabinoid compounds". New Zealand Patent application 623626. Retrieved 11 July 2015.